Jason Napodano

Bio Analyst
Jason Napodano - Twitter

I am a professional sell-side equity research analyst. I currently work for Zacks Investment Research. I started my career with Zacks covering the large-cap Pharma sector in 2003. In 2009, I was promoted to Managing Director of Institutional Equity Research. I now focus on small-cap biotech as a Managing Director & Senior Biotechnology Analyst with Zacks/SCR
Prior to Zacks, I spent 3 years on the buy-side with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology.
Prior to Joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases. I also spent a year working in a lab at the Fralin Biotechnology Center, and a year working for a cancer researcher in Virginia.
I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University.
I am a Chartered Financial Analyst (CFA).

Jason Napodano - Click Here For My RSS Feed

Author Pages

Topic Archives

Topic Archives

Stock Conversation

Shout Box! (NEW)


Name:
Email:
For:

Mail will not be published
(but it's used for avatar)

( Sending... )

Michael Kudrna

(Wednesday, Jun 12. 2013 2:31 PM)

For MikeC, Missed you in chat. For your stock, 10.50 is key support where I’d draw a line in the sand. Above 11.25 would likely make it run higher on a breakout. Currently it’s consolidating nicely with upside potential, but if it doesn’t break out on the first attempt, look for another pullback towards 10.75 area, above support, to possibly reload your position. Easy money seems to have been made, so keep expectations realistic. Hope that helps.

[reply]

Michael Kudrna

(Wednesday, Jun 5. 2013 9:39 AM)

Still no signs of a strong enough support level in GST to start adding more to the position. Will wait patiently to add, but $2 seems more and more likely as it drifts lower

[reply]

Michael Kudrna

(Tuesday, Jun 4. 2013 10:54 AM)

watching and looking to add another increment in GST around 2.44 as it seems to have found short-term stability

[reply]

Michael Kudrna

(Monday, May 20. 2013 11:10 AM)

Keeping tight position in DEJ until we get confirmation of no short-term dilution from management. As Zacks noted, cash ratio is slightly under what they need to keep financing.

[reply]

Michael Kudrna

(Friday, May 17. 2013 12:56 PM)

Added back to GST and looking for the chart to grind higher. Easy money seems to be made, so keep a close eye on your positions.

[reply]

Accreditations

ACCREDITATIONS (click to view):

Recent Stock Talk / Tweets

My Tweets:

Friends of KSMT

Stock Talk Helpful?

Kudrna’s Stock Talk Helpful?

Kudrna's Stock Market Talk

Creating a Trading Community that Shields Market Players from Manipulative Information

Jason Napodano

Recent Posts

Free Subscription Options

Author Pages

Topic Archives

Stock Conversation

Shout Box! (NEW)

Accreditations

ACCREDITATIONS (click to view):

Recent Stock Talk / Tweets

My Tweets:

Friends of KSMT

Friends of KSMT

Kudrna’s Stock Talk Helpful?